Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis-Reference-Cited by-同舟云学术

Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis

Published:2022-01-10 Issue:3 Volume:26 Page:314-322
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Belmouaz Mohamed¹^ORCID,Goussard Guillaume¹,Joly Florent¹,Grand Francois²,Sibille Audrey¹,Ecotiere Laure¹,Desport Estelle¹,Bauwens Marc¹,Thierry Antoine¹,Bridoux Frank¹

Affiliation:

1. Department of Nephrology Poitiers University Hospital Poitiers France

2. Laboratory of Hematology Poitiers University Hospital Poitiers France

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hdi.13004

Reference25 articles.

1. Unfractionated Heparin for Hemodialysis: Still the Best Option

2. V.1 Haemodialysis and prevention of system clotting

3. Anticoagulation for Intermittent Hemodialysis

4. Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments

5. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives;Seminars in Nephrology;2023-11

2. Apply Anticoagulants after Discharge not Benefit to the Incidence of Symptomatic Thrombus in High‐Altitude Areas: A Retrospective Study;Orthopaedic Surgery;2023-10-12

3. Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels;Clinical Pharmacokinetics;2022-08-30